Kyoo Ho Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kyoo Ho Cho has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Phil Hyu Lee
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
8 shared publications Kyoung Heo
Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
7 shared publications- Young Ho Sohn
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
6 shared publications Ji E. Lee
Department of Neurology and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea
4 shared publications- Kyoung Heo
Yonsei University College of Medicine, Seoul, Republic of Korea
4 shared publications Byung In Lee
Department of Neurology, Haeundae Paik Hospital, Inje University College of Medicine, Haeundae-ro 875, Haeundae-gu, Busan, 48108, South Korea
3 shared publications
Latest Publications
- Open Access
- 23 September 2022
- Published by XMLink in Journal of Clinical Neurology
- Vol. 18 (6) , 635-641
Mammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
Cho KH, et al. J Clin Neurol. 2022 Nov;18(6):635-641. https://doi.org/10.3988/jcn.2022.18.6.635
- 23 September 2022
- Published by XMLink in Journal of Clinical Neurology
- Vol. 18 (6) , 635-641
Open AccessMammillary Body Atrophy in Temporal Lobe Epilepsy With Hippocampal Sclerosis
Cho KH, et al. J Clin Neurol. 2022 Nov;18(6):635-641. https://doi.org/10.3988/jcn.2022.18.6.635
- 22 October 2021
- Published by Wiley in Journal of Neuroimaging
- Vol. 32 (2) , 300-313
Metabolic network is related to surgical outcome in temporal lobe epilepsy with hippocampal sclerosis: A brain FDG‐PET study
Background and Purpose: The aim of this study was to investigate differences in metabolic networks based on preoperative fluorodeoxyglucose (FDG)‐positron emission tomography (PET) in temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS) between patients with complete seizure‐free (SF) and those with noncomplete seizure‐free (non‐SF) after anterior temporal lobectomy.Methods: This study was retrospectively performed at a tertiary hospital. We recruited pathologically confirmed 75 TLE patients with HS who underwent preoperative FDG‐PET. All patients underwent a standard anterior temporal lobectomy. The surgical outcome was evaluated at least 12 months after surgery, and we divided the subjects into patients with SF (International League Against Epilepsy [ILAE] class I) and those with non‐SF (ILAE class II‐VI). We evaluated the metabolic network using graph theoretical analysis based on FDG‐PET. We investigated the differences in network measures between the two groups.Results: Of the 75 TLE patients with HS, 32 patients (42.6%) had SF, whereas 43 patients (57.3%) had non‐SF. There were significant differences in global metabolic networks according to surgical outcomes. The patients with SF had a lower assortative coefficient than those with non‐SF (–0.020 vs. –0.009, p = .044). We also found widespread regional differences in local metabolic networks according to surgical outcomes.Conclusion: Our study demonstrates significant differences in preoperative metabolic networks based on FDG‐PET in TLE patients with HS according to surgical outcomes. This work introduces a metabolic network based on FDG‐PET and can be used as a potential tool for predicting surgical outcome in TLE patients with HS.
- 22 October 2021
- Published by Wiley in Journal of Neuroimaging
- Vol. 32 (2) , 300-313
Metabolic network is related to surgical outcome in temporal lobe epilepsy with hippocampal sclerosis: A brain FDG‐PET study
Background and Purpose: The aim of this study was to investigate differences in metabolic networks based on preoperative fluorodeoxyglucose (FDG)‐positron emission tomography (PET) in temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS) between patients with complete seizure‐free (SF) and those with noncomplete seizure‐free (non‐SF) after anterior temporal lobectomy.Methods: This study was retrospectively performed at a tertiary hospital. We recruited pathologically confirmed 75 TLE patients with HS who underwent preoperative FDG‐PET. All patients underwent a standard anterior temporal lobectomy. The surgical outcome was evaluated at least 12 months after surgery, and we divided the subjects into patients with SF (International League Against Epilepsy [ILAE] class I) and those with non‐SF (ILAE class II‐VI). We evaluated the metabolic network using graph theoretical analysis based on FDG‐PET. We investigated the differences in network measures between the two groups.Results: Of the 75 TLE patients with HS, 32 patients (42.6%) had SF, whereas 43 patients (57.3%) had non‐SF. There were significant differences in global metabolic networks according to surgical outcomes. The patients with SF had a lower assortative coefficient than those with non‐SF (–0.020 vs. –0.009, p = .044). We also found widespread regional differences in local metabolic networks according to surgical outcomes.Conclusion: Our study demonstrates significant differences in preoperative metabolic networks based on FDG‐PET in TLE patients with HS according to surgical outcomes. This work introduces a metabolic network based on FDG‐PET and can be used as a potential tool for predicting surgical outcome in TLE patients with HS.
- 19 October 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (16) , e1571-e1582
Multicenter Validation of a Deep Learning Detection Algorithm for Focal Cortical Dysplasia
Background and Objective To test the hypothesis that a multicenter-validated computer deep learning algorithm detects MRI-negative focal cortical dysplasia (FCD). Methods We used clinically acquired 3-dimensional (3D) T1-weighted and 3D fluid-attenuated inversion recovery MRI of 148 patients (median age 23 years [range 2–55 years]; 47% female) with histologically verified FCD at 9 centers to train a deep convolutional neural network (CNN) classifier. Images were initially deemed MRI-negative in 51% of patients, in whom intracranial EEG determined the focus. For risk stratification, the CNN incorporated bayesian uncertainty estimation as a measure of confidence. To evaluate performance, detection maps were compared to expert FCD manual labels. Sensitivity was tested in an independent cohort of 23 cases with FCD (13 ± 10 years). Applying the algorithm to 42 healthy controls and 89 controls with temporal lobe epilepsy disease tested specificity. Results Overall sensitivity was 93% (137 of 148 FCD detected) using a leave-one-site-out cross-validation, with an average of 6 false positives per patient. Sensitivity in MRI-negative FCD was 85%. In 73% of patients, the FCD was among the clusters with the highest confidence; in half, it ranked the highest. Sensitivity in the independent cohort was 83% (19 of 23; average of 5 false positives per patient). Specificity was 89% in healthy and disease controls. Discussion This first multicenter-validated deep learning detection algorithm yields the highest sensitivity to date in MRI-negative FCD. By pairing predictions with risk stratification, this classifier may assist clinicians in adjusting hypotheses relative to other tests, increasing diagnostic confidence. Moreover, generalizability across age and MRI hardware makes this approach ideal for presurgical evaluation of MRI-negative epilepsy. Classification of Evidence This study provides Class III evidence that deep learning on multimodal MRI accurately identifies FCD in patients with epilepsy initially diagnosed as MRI negative.
- 19 October 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 97 (16) , e1571-e1582
Multicenter Validation of a Deep Learning Detection Algorithm for Focal Cortical Dysplasia
Background and Objective To test the hypothesis that a multicenter-validated computer deep learning algorithm detects MRI-negative focal cortical dysplasia (FCD). Methods We used clinically acquired 3-dimensional (3D) T1-weighted and 3D fluid-attenuated inversion recovery MRI of 148 patients (median age 23 years [range 2–55 years]; 47% female) with histologically verified FCD at 9 centers to train a deep convolutional neural network (CNN) classifier. Images were initially deemed MRI-negative in 51% of patients, in whom intracranial EEG determined the focus. For risk stratification, the CNN incorporated bayesian uncertainty estimation as a measure of confidence. To evaluate performance, detection maps were compared to expert FCD manual labels. Sensitivity was tested in an independent cohort of 23 cases with FCD (13 ± 10 years). Applying the algorithm to 42 healthy controls and 89 controls with temporal lobe epilepsy disease tested specificity. Results Overall sensitivity was 93% (137 of 148 FCD detected) using a leave-one-site-out cross-validation, with an average of 6 false positives per patient. Sensitivity in MRI-negative FCD was 85%. In 73% of patients, the FCD was among the clusters with the highest confidence; in half, it ranked the highest. Sensitivity in the independent cohort was 83% (19 of 23; average of 5 false positives per patient). Specificity was 89% in healthy and disease controls. Discussion This first multicenter-validated deep learning detection algorithm yields the highest sensitivity to date in MRI-negative FCD. By pairing predictions with risk stratification, this classifier may assist clinicians in adjusting hypotheses relative to other tests, increasing diagnostic confidence. Moreover, generalizability across age and MRI hardware makes this approach ideal for presurgical evaluation of MRI-negative epilepsy. Classification of Evidence This study provides Class III evidence that deep learning on multimodal MRI accurately identifies FCD in patients with epilepsy initially diagnosed as MRI negative.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (3) , 481-483
Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Positive Encephalitis with Seizure and Unilateral Cortical Fluid-Attenuated Inversion Recovery-Hyperintense Lesions
Kim KH, et al. J Clin Neurol. 2021 Jul;17(3):481-483. https://doi.org/10.3988/jcn.2021.17.3.481
- 1 January 2021
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (3) , 481-483
Open AccessAnti-Myelin Oligodendrocyte Glycoprotein Antibody-Positive Encephalitis with Seizure and Unilateral Cortical Fluid-Attenuated Inversion Recovery-Hyperintense Lesions
Kim KH, et al. J Clin Neurol. 2021 Jul;17(3):481-483. https://doi.org/10.3988/jcn.2021.17.3.481
- 24 June 2020
- Published by Springer Nature in Neurocritical Care
- Vol. 34 (1) , 248-258
Cerebral Infarction Observed on Brain MRI in Unconscious Out-of-Hospital Cardiac Arrest Survivors: A Pilot Study
Background Cumulative evidence regarding the use of brain magnetic resonance imaging (MRI) for predicting prognosis of unconscious out-of-hospital cardiac arrest (OHCA) survivors treated with targeted temperature management (TTM) is available. Theoretically, these patients are at a high risk of developing cerebral infarction. However, there is a paucity of reports regarding the characteristics of cerebral infarction in this population. Thus, we performed a pilot study to identify the characteristics and risk factors of cerebral infarction and to evaluate whether this infarction is associated with clinical outcomes. Methods A single-center, retrospective, registry-based cohort study was conducted at Severance Hospital, a tertiary center. Unconscious OHCA survivors were registered and treated with TTM between September 2011 and December 2015. We included patients who underwent brain MRI in the first week after the return of spontaneous circulation. We excluded patients who underwent any endovascular interventions to focus on “procedure-unrelated” cerebral infarctions. We assessed hypoxic–ischemic encephalopathy (HIE) and procedure-unrelated cerebral infarction separately on MRI. Patients were categorized into the following groups based on MRI findings: HIE (−)/infarction (−), infarction-only, and HIE (+) groups. Conventional vascular risk factors showing p < 0.05 in univariate analyses were entered into multivariate logistic regression. We also evaluated if the presence of this procedure-unrelated cerebral infarction lesion or HIE was associated with a poor clinical outcome at discharge, defined as a cerebral performance category of 3–5. Results Among 71 unconscious OHCA survivors who completed TTM, underwent MRI, and who did not undergo endovascular interventions, 14 (19.7%) patients had procedure-unrelated cerebral infarction based on MRI. Advancing age [odds ratio (OR) 1.11] and atrial fibrillation (OR 5.78) were independently associated with the occurrence of procedure-unrelated cerebral infarction (both p < 0.05). There were more patients with poor clinical outcomes at discharge in the HIE (+) group (88.1%) than in the infarction-only (30.0%) or HIE (−)/infarction (−) group (15.8%) (p < 0.001). HIE (+) (OR 38.69, p < 0.001) was independently associated with poor clinical outcomes at discharge, whereas infarction-only was not (p > 0.05), compared to HIE (−)/infarction (−). Conclusions In this pilot study, procedure-unrelated cerebral infarction was noted in approximately one-fifth of unconscious OHCA survivors who were treated with TTM and underwent MRI. Older age and atrial fibrillation might be associated with the occurrence of procedure-unrelated cerebral infarction, and cerebral infarction was not considered to be associated with clinical outcomes at discharge. Considering that the strict exclusion criteria in this pilot study resulted in a highly selected sample with a relatively small size, further work is needed to verify our findings.
- 24 June 2020
- Published by Springer Nature in Neurocritical Care
- Vol. 34 (1) , 248-258
Cerebral Infarction Observed on Brain MRI in Unconscious Out-of-Hospital Cardiac Arrest Survivors: A Pilot Study
Background Cumulative evidence regarding the use of brain magnetic resonance imaging (MRI) for predicting prognosis of unconscious out-of-hospital cardiac arrest (OHCA) survivors treated with targeted temperature management (TTM) is available. Theoretically, these patients are at a high risk of developing cerebral infarction. However, there is a paucity of reports regarding the characteristics of cerebral infarction in this population. Thus, we performed a pilot study to identify the characteristics and risk factors of cerebral infarction and to evaluate whether this infarction is associated with clinical outcomes. Methods A single-center, retrospective, registry-based cohort study was conducted at Severance Hospital, a tertiary center. Unconscious OHCA survivors were registered and treated with TTM between September 2011 and December 2015. We included patients who underwent brain MRI in the first week after the return of spontaneous circulation. We excluded patients who underwent any endovascular interventions to focus on “procedure-unrelated” cerebral infarctions. We assessed hypoxic–ischemic encephalopathy (HIE) and procedure-unrelated cerebral infarction separately on MRI. Patients were categorized into the following groups based on MRI findings: HIE (−)/infarction (−), infarction-only, and HIE (+) groups. Conventional vascular risk factors showing p < 0.05 in univariate analyses were entered into multivariate logistic regression. We also evaluated if the presence of this procedure-unrelated cerebral infarction lesion or HIE was associated with a poor clinical outcome at discharge, defined as a cerebral performance category of 3–5. Results Among 71 unconscious OHCA survivors who completed TTM, underwent MRI, and who did not undergo endovascular interventions, 14 (19.7%) patients had procedure-unrelated cerebral infarction based on MRI. Advancing age [odds ratio (OR) 1.11] and atrial fibrillation (OR 5.78) were independently associated with the occurrence of procedure-unrelated cerebral infarction (both p < 0.05). There were more patients with poor clinical outcomes at discharge in the HIE (+) group (88.1%) than in the infarction-only (30.0%) or HIE (−)/infarction (−) group (15.8%) (p < 0.001). HIE (+) (OR 38.69, p < 0.001) was independently associated with poor clinical outcomes at discharge, whereas infarction-only was not (p > 0.05), compared to HIE (−)/infarction (−). Conclusions In this pilot study, procedure-unrelated cerebral infarction was noted in approximately one-fifth of unconscious OHCA survivors who were treated with TTM and underwent MRI. Older age and atrial fibrillation might be associated with the occurrence of procedure-unrelated cerebral infarction, and cerebral infarction was not considered to be associated with clinical outcomes at discharge. Considering that the strict exclusion criteria in this pilot study resulted in a highly selected sample with a relatively small size, further work is needed to verify our findings.
- 10 January 2020
- Published by Springer Nature in Journal of Neurology
- Vol. 267 (4) , 1179-1187
Predicting the antiepileptic drug response by brain connectivity in newly diagnosed focal epilepsy
Objective Growing evidence has suggested that epilepsy is a disease with alterations in brain connectivity. The aim of this study was to investigate whether the changes in brain connectivity can predict the response to an antiepileptic drug (AED) in patients with a newly diagnosed focal epilepsy of unknown etiology. Methods This observational study was independently performed at two tertiary hospitals (Group A and B). Thirty-eight patients with newly diagnosed focal epilepsy of unknown etiology were enrolled in Group A and 46 patients in Group B. We divided these patients into two groups according to their seizure control after AED treatment: AED good and poor responders. We defined the AED good responders as those in whom had seizure free for at least the last 6 months while AED poor responders who were not. All of the subjects underwent diffusion tensor imaging, and graph theoretical analysis was applied to reveal the brain connectivity. We investigated the difference in the clinical characteristics and network measurements between the two groups. Results Of the network measures, the assortativity coefficient in the AED good responders was significantly higher than that in the AED poor responders in both Groups A and B (− 0.0239 vs. − 0.0473, p = 0.0110 in Group A; 0.0173 vs. − 0.0180, p = 0.0024 in Group B). The Kaplan–Meier survival analysis revealed that the time to failure to retain the first AED was significantly longer in the patients with assortative networks (assortativity coefficient > 0) than in those with disassortative networks (assortativity coefficient < 0) in Group B. Conclusion We demonstrated that the assortativity coefficient differed between patients with newly diagnosed focal epilepsy of unknown etiology according to their AED responses, which suggests that the changes in brain connectivity could be a biomarker for predicting the responses to AED.
- 10 January 2020
- Published by Springer Nature in Journal of Neurology
- Vol. 267 (4) , 1179-1187
Predicting the antiepileptic drug response by brain connectivity in newly diagnosed focal epilepsy
Objective Growing evidence has suggested that epilepsy is a disease with alterations in brain connectivity. The aim of this study was to investigate whether the changes in brain connectivity can predict the response to an antiepileptic drug (AED) in patients with a newly diagnosed focal epilepsy of unknown etiology. Methods This observational study was independently performed at two tertiary hospitals (Group A and B). Thirty-eight patients with newly diagnosed focal epilepsy of unknown etiology were enrolled in Group A and 46 patients in Group B. We divided these patients into two groups according to their seizure control after AED treatment: AED good and poor responders. We defined the AED good responders as those in whom had seizure free for at least the last 6 months while AED poor responders who were not. All of the subjects underwent diffusion tensor imaging, and graph theoretical analysis was applied to reveal the brain connectivity. We investigated the difference in the clinical characteristics and network measurements between the two groups. Results Of the network measures, the assortativity coefficient in the AED good responders was significantly higher than that in the AED poor responders in both Groups A and B (− 0.0239 vs. − 0.0473, p = 0.0110 in Group A; 0.0173 vs. − 0.0180, p = 0.0024 in Group B). The Kaplan–Meier survival analysis revealed that the time to failure to retain the first AED was significantly longer in the patients with assortative networks (assortativity coefficient > 0) than in those with disassortative networks (assortativity coefficient < 0) in Group B. Conclusion We demonstrated that the assortativity coefficient differed between patients with newly diagnosed focal epilepsy of unknown etiology according to their AED responses, which suggests that the changes in brain connectivity could be a biomarker for predicting the responses to AED.
Volume change in amygdala enlargement as a prognostic factor in patients with temporal lobe epilepsy: A longitudinal study
Objective: Considering the clinical heterogeneity of temporal lobe epilepsy with amygdala enlargement (TLE‐AE), identifying distinct prognostic subgroups of TLE‐AE has clinical implications. Until now, baseline volume of the enlarged amygdala (EAV) has consistently failed to predict prognosis in TLE‐AE. Based on studies suggesting that patients responsive to antiepileptic drugs (AEDs) exhibit remission of AE on follow‐up imaging, we investigated whether reduction rate of EAV is predictive of long‐term prognosis in TLE‐AE.Methods: Sixty‐one consecutive patients with two separate magnetic resonance imaging (MRI) scans were enrolled. To utilize longitudinally measured biomarkers in prediction, the period beyond the first MRI acquisition was split into two periods: the “observation window” (period between the two MRIs) and “prediction window” (follow‐up period beyond the second MRI). Patients were classified according to their AED responsiveness during the observation window, and AED‐responsive patients were further subdivided by initial seizure frequency: (a) AED‐responsive patients presenting with low‐frequency seizures (<5 seizures/3 mo; Group A, n = 25), (b) high‐frequency seizures (≥5 seizures/3 mo; Group B, n = 23), and (c) patients with poor initial treatment response (Group C, n = 13). Multivariate logistic regression models were constructed for identification of prognostic factors. Along with factors obtained at baseline, factors derived from the observation window (annual percentage change of EAV [APCEAV] and initial AED responsiveness) were also considered as potential predictors.Results: Favorable initial treatment response and faster volume reduction rate (APCEAV ≤ −5.0%/y) were identified as factors predictive of achieving overall seizure freedom. Among the AED‐responsive patients, Group A (low‐frequency seizures) showed slower remission of AE and higher rate of seizure recurrence, whereas Group B (high‐frequency seizures) exhibited faster remission of AE and lower rate of seizure recurrence.Significance: Faster recuperation of AE in patients with initial high‐frequency seizures may be indicative of seizure‐induced changes. As volume reduction rate serves as a prognostic marker in TLE‐AE, short‐term MRI follow‐up may be useful in prognostication.
Volume change in amygdala enlargement as a prognostic factor in patients with temporal lobe epilepsy: A longitudinal study
Objective: Considering the clinical heterogeneity of temporal lobe epilepsy with amygdala enlargement (TLE‐AE), identifying distinct prognostic subgroups of TLE‐AE has clinical implications. Until now, baseline volume of the enlarged amygdala (EAV) has consistently failed to predict prognosis in TLE‐AE. Based on studies suggesting that patients responsive to antiepileptic drugs (AEDs) exhibit remission of AE on follow‐up imaging, we investigated whether reduction rate of EAV is predictive of long‐term prognosis in TLE‐AE.Methods: Sixty‐one consecutive patients with two separate magnetic resonance imaging (MRI) scans were enrolled. To utilize longitudinally measured biomarkers in prediction, the period beyond the first MRI acquisition was split into two periods: the “observation window” (period between the two MRIs) and “prediction window” (follow‐up period beyond the second MRI). Patients were classified according to their AED responsiveness during the observation window, and AED‐responsive patients were further subdivided by initial seizure frequency: (a) AED‐responsive patients presenting with low‐frequency seizures (<5 seizures/3 mo; Group A, n = 25), (b) high‐frequency seizures (≥5 seizures/3 mo; Group B, n = 23), and (c) patients with poor initial treatment response (Group C, n = 13). Multivariate logistic regression models were constructed for identification of prognostic factors. Along with factors obtained at baseline, factors derived from the observation window (annual percentage change of EAV [APCEAV] and initial AED responsiveness) were also considered as potential predictors.Results: Favorable initial treatment response and faster volume reduction rate (APCEAV ≤ −5.0%/y) were identified as factors predictive of achieving overall seizure freedom. Among the AED‐responsive patients, Group A (low‐frequency seizures) showed slower remission of AE and higher rate of seizure recurrence, whereas Group B (high‐frequency seizures) exhibited faster remission of AE and lower rate of seizure recurrence.Significance: Faster recuperation of AE in patients with initial high‐frequency seizures may be indicative of seizure‐induced changes. As volume reduction rate serves as a prognostic marker in TLE‐AE, short‐term MRI follow‐up may be useful in prognostication.
- Open Access
- 18 November 2019
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-4
A case of dyskinesia after levetiracetam administration
Background: Antiepileptic drug (AED) induced dyskinesia is an unusual manifestation in the medical field. In the previous case reports describing first generation-AED related involuntary movements, the authors suggested that a plausible cause is pharmacokinetic interactions between two or more AEDs. To date, development of dyskinesia after levetiracetam (LEV) has not been reported. Case presentation: A 28-year-old woman with a history of brain metastasis from spinal cord glioblastoma presented with several generalized tonic-clonic seizures without restored consciousness. LEV was administered intravenously. Thereafter no more clinical or electroencephalographic seizures were noted on video-EEG monitoring, while chorea movement was observed in her face and bilateral upper limbs. Discussion and conclusions: To our knowledge, there is no case report of dyskinesia after administration of LEV. Considering the temporal relationship and absence of ictal video-EEG findings, we suggest that development of choreoathetosis was closely associated with the undesirable effects of LEV. We propose that dopaminergic system dysregulation and genetic susceptibility might underlie this unusual phenomenon after LEV treatment.
- 18 November 2019
- Published by Springer Nature in BMC Neurology
- Vol. 19 (1) , 1-4
Open AccessA case of dyskinesia after levetiracetam administration
Background: Antiepileptic drug (AED) induced dyskinesia is an unusual manifestation in the medical field. In the previous case reports describing first generation-AED related involuntary movements, the authors suggested that a plausible cause is pharmacokinetic interactions between two or more AEDs. To date, development of dyskinesia after levetiracetam (LEV) has not been reported. Case presentation: A 28-year-old woman with a history of brain metastasis from spinal cord glioblastoma presented with several generalized tonic-clonic seizures without restored consciousness. LEV was administered intravenously. Thereafter no more clinical or electroencephalographic seizures were noted on video-EEG monitoring, while chorea movement was observed in her face and bilateral upper limbs. Discussion and conclusions: To our knowledge, there is no case report of dyskinesia after administration of LEV. Considering the temporal relationship and absence of ictal video-EEG findings, we suggest that development of choreoathetosis was closely associated with the undesirable effects of LEV. We propose that dopaminergic system dysregulation and genetic susceptibility might underlie this unusual phenomenon after LEV treatment.
- Open Access
- 1 November 2019
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 22 (3) , 16657-16665
Regional Connectivity Changes According to Seizure Outcome of Temporal Epilepsy Surgery: A Magnetoencephalography Study
For patients with medically intractable temporal lobe epilepsy (TLE), anterior temporal resection has been mostly frequent treatment...
- 1 November 2019
- Published by Biomedical Research Network, LLC in Biomedical Journal of Scientific & Technical Research
- Vol. 22 (3) , 16657-16665
Open AccessRegional Connectivity Changes According to Seizure Outcome of Temporal Epilepsy Surgery: A Magnetoencephalography Study
For patients with medically intractable temporal lobe epilepsy (TLE), anterior temporal resection has been mostly frequent treatment...
- Top Cited PapersOpen Access
- 13 August 2019
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 849
The Effect of Anxiety and Depression on Sleep Quality of Individuals With High Risk for Insomnia: A Population-Based Study
Introduction: One of the most common sleep disorders, insomnia is a significant public health concern. Several psychiatric disorders, such as anxiety disorders and depression, have shown strong relationships with insomnia. However, the clinical impact of the combination of these two conditions on insomnia severity and sleep quality remains unknown. We investigated the relationship between sleep disturbance and psychiatric comorbidities in subjects with high risk for insomnia. Methods: We analyzed data from a nation-wide cross-sectional survey of Korean adults aged 19 ~ 69 years conducted from November 2011 to January 2012. The survey was performed via face-to-face interviews using a structured questionnaire. We used the insomnia severity index (ISI) to evaluate insomnia and defined respondents with ISI scores of ≥10 were considered to be at high risk for insomnia. To diagnose anxiety and depression, we used the Goldberg anxiety scale (GAS) and Patient Health Questionnaire-9 (PHQ-9), respectively. Results: Of the 2,762 respondents, 290 (10.5%) were classified as subjects with high risk for insomnia; anxiety [odds ratio (OR), 9.8; 95% confidence interval (CI), 7.3–13.1] and depression (OR, 19.7; 95% CI, 13.1–29.6) were more common in this population than in participants without insomnia. Of the participants with insomnia, 152 (52.4%) had neither anxiety nor depression, 63 (21.7%) only had anxiety, 21 (7.2%) only had depression, and 54 (18.6%) had both anxiety and depression. The group with both anxiety and depression was associated with worse scores on sleep-related scales than the other groups [high ISI, Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale]. The relationship between outcome measures (ISI and PSQI) and psychiatric problems was significant only when anxiety and depression were present. The PSQI has a significant mediation effect on the relationship between psychiatric comorbidities and insomnia severity. Conclusion: Among the respondents with insomnia, psychiatric comorbidities may have a negative impact on daytime alertness, general sleep quality, and insomnia severity, especially when the two conditions are present at the same time. Clinicians should, therefore, consider psychiatric comorbidities when treating insomnia.
- 13 August 2019
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 849
Top Cited PapersOpen AccessThe Effect of Anxiety and Depression on Sleep Quality of Individuals With High Risk for Insomnia: A Population-Based Study
Introduction: One of the most common sleep disorders, insomnia is a significant public health concern. Several psychiatric disorders, such as anxiety disorders and depression, have shown strong relationships with insomnia. However, the clinical impact of the combination of these two conditions on insomnia severity and sleep quality remains unknown. We investigated the relationship between sleep disturbance and psychiatric comorbidities in subjects with high risk for insomnia. Methods: We analyzed data from a nation-wide cross-sectional survey of Korean adults aged 19 ~ 69 years conducted from November 2011 to January 2012. The survey was performed via face-to-face interviews using a structured questionnaire. We used the insomnia severity index (ISI) to evaluate insomnia and defined respondents with ISI scores of ≥10 were considered to be at high risk for insomnia. To diagnose anxiety and depression, we used the Goldberg anxiety scale (GAS) and Patient Health Questionnaire-9 (PHQ-9), respectively. Results: Of the 2,762 respondents, 290 (10.5%) were classified as subjects with high risk for insomnia; anxiety [odds ratio (OR), 9.8; 95% confidence interval (CI), 7.3–13.1] and depression (OR, 19.7; 95% CI, 13.1–29.6) were more common in this population than in participants without insomnia. Of the participants with insomnia, 152 (52.4%) had neither anxiety nor depression, 63 (21.7%) only had anxiety, 21 (7.2%) only had depression, and 54 (18.6%) had both anxiety and depression. The group with both anxiety and depression was associated with worse scores on sleep-related scales than the other groups [high ISI, Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleepiness Scale]. The relationship between outcome measures (ISI and PSQI) and psychiatric problems was significant only when anxiety and depression were present. The PSQI has a significant mediation effect on the relationship between psychiatric comorbidities and insomnia severity. Conclusion: Among the respondents with insomnia, psychiatric comorbidities may have a negative impact on daytime alertness, general sleep quality, and insomnia severity, especially when the two conditions are present at the same time. Clinicians should, therefore, consider psychiatric comorbidities when treating insomnia.